UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers

Oncogene, 2016-01, Vol.35 (2), p.173-186

2016

Volltextzugriff (PDF)

Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: A SEER database analysis of 162,983 cases

Cancer, 2018-02, Vol.124 (4), p.807-815

2018

Volltextzugriff (PDF)

A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers

British journal of cancer, 2021-11, Vol.125 (10), p.1333-1340

2021

Volltextzugriff (PDF)

Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer

Annals of oncology, 2022-01, Vol.33 (1), p.42-56

2022

Volltextzugriff (PDF)

Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices

CA: a cancer journal for clinicians, 2006-11, Vol.56 (6), p.323-353

2006

Volltextzugriff (PDF)

Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC

Journal of thoracic oncology, 2019-12, Vol.14 (12), p.2152-2163

2019

Volltextzugriff (PDF)

The MEK5-ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer

Cancer research (Chicago, Ill.), 2020-03, Vol.80 (6), p.1293-1303

2020

Volltextzugriff (PDF)

STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype

Journal of thoracic oncology, 2020-05, Vol.15 (5), p.777-791

2020

Volltextzugriff (PDF)

Altering the Course of Small Cell Lung Cancer: Targeting Cancer Stem Cells via LSD1 Inhibition

Cancer cell, 2015-07, Vol.28 (1), p.4-6

2015

Volltextzugriff (PDF)

Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer

Oncotarget, 2017-04, Vol.8 (17), p.28575-28587

2017

Volltextzugriff (PDF)

Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer

Clinical cancer research, 2023-08, Vol.29 (16), p.3237-3249

2023

Volltextzugriff (PDF)

AXL Inhibition Induces DNA Damage and Replication Stress in Non-Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors

Molecular cancer research, 2021-03, Vol.19 (3), p.485-497

2021

Volltextzugriff (PDF)

Myb Permits Multilineage Airway Epithelial Cell Differentiation

Stem cells (Dayton, Ohio), 2014-12, Vol.32 (12), p.3245-3256

2014

Volltextzugriff (PDF)

Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer

British journal of cancer, 2022-08, Vol.127 (3), p.569-576

2022

Volltextzugriff (PDF)

Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer

Cancer & metabolism, 2021-09, Vol.9 (1), p.33-33, Article 33

2021

Volltextzugriff (PDF)

Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide

Lung cancer (Amsterdam, Netherlands), 2023-12, Vol.186, p.107418-107418, Article 107418

2023

Volltextzugriff (PDF)

SLFN11 biomarker status predicts response to lurbinectedin as a single agent and in combination with ATR inhibition in small cell lung cancer

Translational lung cancer research, 2021-11, Vol.10 (11), p.4095-4105

2021

Volltextzugriff (PDF)

Guidelines for Colonoscopy Surveillance after Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society

CA: a cancer journal for clinicians, 2006-05, Vol.56 (3), p.143-159

2006

Volltextzugriff (PDF)

VP5-2021: IMpower133: Gene expression (GE) analysis in long-term survivors (LTS) with ES-SCLC treated with first-line carboplatin and etoposide (CE) ± atezolizumab (atezo)

Annals of oncology, 2021-08, Vol.32 (8), p.1063-1065

2021

Volltextzugriff (PDF)

β-catenin affects androgen receptor transcriptional activity and ligand specificity

Cancer research (Chicago, Ill.), 2000-09, Vol.60 (17), p.4709-4713

2000

Volltextzugriff (PDF)

Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices

CA: a cancer journal for clinicians, 2003-09, Vol.53 (5), p.268-291

2003

Volltextzugriff (PDF)

Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses

Journal of thoracic oncology, 2020-02, Vol.15 (2), p.274-287

2020

Volltextzugriff (PDF)

American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer with Healthy Food Choices and Physical Activity

CA: a cancer journal for clinicians, 2002-03, Vol.52 (2), p.92-119

2002

Volltextzugriff (PDF)

Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

CA: a cancer journal for clinicians, 2008-05, Vol.58 (3), p.130-160

2008

Volltextzugriff (PDF)

Intra-tumoural microvessel density in human solid tumours

British journal of cancer, 2002-05, Vol.86 (10), p.1566-1577

2002

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Aktive Filter

ThemaFemale

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(56)

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(55)
Science & Technology
(55)
Humans
(42)
Lung Neoplasms - Drug Therapy
(11)
Animals
(10)
Tumors
(10)
Biological And Medical Sciences
(9)
Cancer
(9)
Medical Sciences
(9)
Cell Line, Tumor
(8)
Lung Neoplasms - Pathology
(8)
Cell Biology
(7)
Lung Cancer
(7)
Mice
(7)
Respiratory System
(7)
Small Cell Lung Carcinoma - Drug Therapy
(7)
Apoptosis
(6)
Biomarkers
(6)
Cancer Research
(6)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers

Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: A SEER database analysis of 162,983 cases

A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers

Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer

Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices

Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC

The MEK5-ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer

STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype

Altering the Course of Small Cell Lung Cancer: Targeting Cancer Stem Cells via LSD1 Inhibition

Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer

Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer

AXL Inhibition Induces DNA Damage and Replication Stress in Non-Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors

Myb Permits Multilineage Airway Epithelial Cell Differentiation

Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer

Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer

Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide

SLFN11 biomarker status predicts response to lurbinectedin as a single agent and in combination with ATR inhibition in small cell lung cancer

Guidelines for Colonoscopy Surveillance after Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society

VP5-2021: IMpower133: Gene expression (GE) analysis in long-term survivors (LTS) with ES-SCLC treated with first-line carboplatin and etoposide (CE) ± atezolizumab (atezo)

β-catenin affects androgen receptor transcriptional activity and ligand specificity

Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices

Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses

American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer with Healthy Food Choices and Physical Activity

Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

Intra-tumoural microvessel density in human solid tumours

Aktive Filter

Suchergebnisse filtern